DQAsomes as mitochondria-targeted nanocarriersfor anti-cancer drugs

Nanotechnology for Cancer Therapy

Volumn , Issue , 2006, Pages 787-802

  Cheng, Shing Ming ^a   Boddapati, Sarathi V ^a   D'Souza, Gerard G M ^a   Weissig, Volkmar ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886048796     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (108)

1. Costantini, P., Jacotot, E., Decaudin, D., and Kroemer, G., Mitochondrion as anovel target of anticancer chemotherapy, J. Natl. Cancer Inst., 92(13), 1042-1053, 2000.
2. Galati, G., Teng, S., Moridani, M. Y., Chan, T. S., and O'Brien, P. J., Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics, Drug Metabol. Drug Interact., 17(1-44), 311-349, 2000.
3. Ghafourifar, P., Bringold, U., Klein, S. D., and Richter, C., Mitochondrial nitric oxide synthase, oxidative stress and apoptosis, Biol. Signals Recept., 10(1-2), 57-65, 2001.
4. Davis, W., Ronai, Z., and Tew, K. D., Cellular thiols and reactive oxygen species in drug-induced apoptosis, J. Pharmacol. Exp. Ther., 296(1), 1-6, 2001.
5. Creagh, E. M., Sheehan, D., and Cotter, T. G., Heat shock proteins-modulators of apoptosis in tumour cells, Leukemia, 14(7), 1161-1173, 2000.
6. Hall, A. G., Review: The role of glutathione in the regulation of apoptosis, Eur. J. Clin. Invest., 29(3), 238-245, 1999.
7. Deigner, H. P. and Kinscherf, R., Modulating apoptosis: Current applications and prospects for future drug development, Curr. Med. Chem., 6(5), 399-114, 1999.
8. Peltenburg, L. T., Radiosensitivity of tumor cells. Oncogenes and apoptosis, Q. J. Nucl. Med., 44(4), 355-364, 2000.
9. Deigner, H. P., Haberkorn, U., and Kinscherf, R., Apoptosis modulators in the therapy of neurodegenerative diseases, Expert Opin. Investig. Drugs, 9(4), 747-764, 2000.
10. Kanduc, D., Mittelman, A., Serpico, R., Sinigaglia, E., Sinha, A. A., Natale, C., Santacroce, R., Di Corcia, M. G. et al., Cell death: Apoptosis versus necrosis (review), Int. J. Oncol., 21(Y), 165-170, 2002.
11. Robertson, J. D., Orrenius, S., and Zhivotovsky, B., Review: Nuclear events in apoptosis, J. Struct. Biol., 129(2, 3), 346-358, 2000.
12. Tomei, L. D. and Umansky, S. R., Apoptosis and the heart: Abrief review, Ann. N. Y.Acad. Sci., 946, 160-168, 2001.
13. Sathasivam, S., Ince, P. G., and Shaw, P. J., Apoptosis in amyotrophic lateral sclerosis: Areview of the evidence, Neuropathol. Appl. Neurobiol., 27(4), 257-274, 2001.
14. Tinaztepe, K., Ozen, S., Gucer, S., and Ozdamar, S., Apoptosis in renal disease: Abrief review of the literature and report of preliminary findings in childhood lupus nephritis, Turk. J. Pediatr., 43(2), 133-138, 2001.
15. Zusman, I., Gurevich, P., Gurevich, E., and Ben-Hur, H., The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review), Int. J. Oncol., 18(5), 965-972, 2001.
16. Belzacq, A. S., Vieira, H. L., Kroemer, G., and Brenner, C., The adenine nucleotide translocator in apoptosis, Biochimie, 84(2, 3), 167-176, 2002.
17. Kaufmann, S. H. and Gores, G. J., Apoptosis in cancer: Cause and cure, Bioessays, 22(11), 1007-1017, 2000.
18. Olson, M. and Kornbluth, S., Mitochondria in apoptosis and human disease, Curr. Mol. Med., 1(1), 91-122, 2001.
19. Lin, Q. S., Mitochondria and apoptosis, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 31(2), 116-118, 1999.
20. Pollack, M. and Leeuwenburgh, C., Apoptosis and aging: Role of the mitochondria, J. Gerontol. A Biol. Sci. Med. Sci., 56(11), B475-B482, 2001.
21. Henkart, P. A. and Grinstein, S., Apoptosis: Mitochondria resurrected? J. Exp. Med., 183(4), 1293-1295, 1996.
22. Skulachev, V. P., Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell, FEBS Lett., 397(1), 7-10, 1996.
23. Petit, P. X., Zamzami, N., Vayssiere, J. L., Mignotte, B., Kroemer, G., and Castedo, M., Implication of mitochondria in apoptosis, Mol. Cell. Biochem., 174(1, 2), 185-188, 1997.
24. Decaudin, D., Marzo, I, Brenner, C., and Kroemer, G., Mitochondria in chemotherapy-induced apoptosis: Aprospective novel target of cancer therapy (review), Int. J. Oncol., 12(1), 141-152, 1998.
25. Mignotte, B. and Vayssiere, J. L., Mitochondria and apoptosis, Eur. J. Biochem., 252(Y), 1-15, 1998.
26. Susin, S. A., Zamzami, N., and Kroemer, G., Mitochondria as regulators of apoptosis: Doubt no more, Biochim. Biophys. Acta, 1366(1, 2), 151-165, 1998.
27. Green, D. R. and Reed, J. C., Mitochondria and apoptosis, Science, 281(5381), 1309-1312, 1998.
28. Tatton, W. G. and Chalmers-Redman, R. M., Mitochondria in neurodegenerative apoptosis: An opportunity for therapy? Ann. Neurol., 44(3 Suppl. 1), S134-S141, 1998.
29. Gottlieb, R. A., Mitochondria: Ignition chamber for apoptosis, Mol. Genet. Metab., 68(2), 227-231, 1999.
30. Nieminen, A. L., Apoptosis and necrosis in health and disease: Role of mitochondria, Int. Rev. Cytol., 224, 29-55, 2003.
31. Weber, T., Dalen, H., Andera, L., Negre-Salvayre, A., Auge, N., Sticha, M., Lloret, A. et al., Mitochondria play acentral role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: Comparison with receptor-mediated pro-apoptotic signaling, Biochemistry, 42(14), 4277-4291, 2003.
32. Richter, C., Oxidative Stress, mitochondria, and apoptosis, Restor. Neurol. Neurosci., 12(2, 3), 59-62, 1998.
33. Gulbins, E., Dreschers, S., and Bock, J., Role of mitochondria in apoptosis, Exp. Physiol., 88(Pt 1), 85-90, 2003.
34. Hockenbery, D. M., Giedt, C. D., O'Neill, J. W., Manion, M. K., and Banker, D. E., Mitochondria and apoptosis: New therapeutic targets, Adv. Cancer Res., 85, 203-242, 2002.
35. Heiligtag, S. J., Bredehorst, R., and David, K. A., Key role of mitochondria in cerulenin-mediated apoptosis, Cell Death Differ., 9(9), 1017-1025, 2002.
36. Boichuk, S. V., Minnebaev, M. M., and Mustafin, I. G., Key role of mitochondria in apoptosis of lymphocytes, Bull. Exp. Biol. Med., 132(6), 1166-1168, 2001.
37. Birbes, H., Bawab, S. E., Obeid, L. M., and Hannun, Y. A., Mitochondria and ceramide: Intertwined roles in regulation of apoptosis, Adv. Enzyme Regul., 42, 113-129, 2002.
38. Naoi, M., Maruyama, W., Akao, Y., and Yi, H., Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargy-lamines, J. Neural Transm., 109(5, 6), 607-621, 2002.
39. Roucou, X., Antonsson, B., and Martinou, J. C., Involvement of mitochondria in apoptosis, Cardiol. Clin., 19(1), 45-55, 2001.
40. Wang, X., The expanding role of mitochondria in apoptosis, Genes Dev., 15(22), 2922-2933, 2001.
41. Raha, S. and Robinson, B. H., Mitochondria, oxygen free radicals, and apoptosis, Am. J. Med. Genet., 106(1), 62-70, 2001.
42. Waterhouse, N. J., Goldstein, J. C., Kluck, R. M., Newmeyer, D. D., and Green, D. R., The (Holey) study of mitochondria in apoptosis, Methods Cell Biol., 66, 365-391, 2001.
43. Sordet, O., Rebe, C., Leroy, I., Bruey, J. M., Garrido, C., Miguet, C., Lizard, G., Plenchette, S., Corcos, L., and Solary, E., Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis, Blood, 97(12), 3931-3940, 2001.
44. Gottlieb, R. A., Mitochondria and apoptosis, Biol. Signals Recept., 10(3, 4), 147-161, 2001.
45. Shi, Y., Astructural view of mitochondria-mediated apoptosis, Nat. Struct. Biol., 8(5), 394-401, 2001.
46. Gottlieb, R. A., Role of mitochondria in apoptosis, Crit. Rev. Eukaryot. Gene. Expr., 10(3, 4), 231-239, 2000.
47. Jiang, Z. F., Zhao, Y., Hong, X., and Zhai, Z. H., Nuclear apoptosis induced by isolated mitochondria, Cell Res., 10(3), 221-232, 2000.
48. Brenner, C. and Kroemer, G., Apoptosis. Mitochondria-the death signal integrators, Science, 289(5482), 1150-1151, 2000.
49. Desagher, S. and Martinou, J. C., Mitochondria as the central control point of apoptosis, Trends Cell Biol., 10(9), 369-377, 2000.
50. Kroemer, G., Mitochondrial control of apoptosis: An overview, In Mitochondria and Cell Death, Brown, G. C., Nicholls, D. G., and Cooper, C. E., Eds., Princton University Press, Princeton, NJ, pp. 1-15, 1999.
51. Fulda, S., Susin, S. A., Kroemer, G., and Debatin, K. M., Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells, Cancer Res., 58(19), 4453-4460, 1998.
52. Ferlini, C., Raspaglio, G., Mozzetti, S., Distefano, M., Filippetti, F., Martinelli, E., Ferrandina, G., Gallo, D., Ranelletti, F. O., and Scambia, G., Bcl-2 down-regulation is anovel mechanism of paclitaxel resistance, Mol. Pharmacol., 64(1), 51-58, 2003.
53. von Haefen, C., Wieder, T., Essmann, F., Schulze-Osthoff, K., Dorken, B., and Daniel, P. T., Paclitaxel-induced apoptosis in BJAB cells proceeds via adeath receptor-independent, caspases-3/-8-driven mitochondrial amplification loop, Oncogene, 22(15), 2236-2247, 2003.
54. Andre, N., Carre, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C., and Braguer, D., Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells, FEBS Lett., 532(1-2), 256-260, 2002.
55. Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., and Thorn, P., Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore, J. Biol. Chem., 277(8), 6504-6510, 2002.
56. Makin, G. W., Corfe, B. M., Griffiths, G. J., Thistlethwaite, A., Hickman, J. A., and Dive, C., Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate, Embo J., 20(22), 6306-6315, 2001.
57. Varbiro, G., Veres, B., Gallyas, F., and Sumegi, B., Direct effect of Taxol on free radical formation and mitochondrial permeability transition, Free Radic. Biol. Med., 31(4), 548-558, 2001.
58. Andre, N., Braguer, D., Brasseur, G., Goncalves, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., and Briand, C., Paclitaxel induces release of cytochrome cfrom mitochondria isolated from human neuroblastoma cells', Cancer Res., 60(19), 5349-5353, 2000.
59. Carre, M., Carles, G., Andre, N., Douillard, S., Ciccolini, J., Briand, C., and Braguer, D., Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis, Biochem. Pharmacol., 63(10), 1831-1842, 2002.
60. Perkins, C. L., Fang, G., Kim, C. N., and Bhalla, K. N., The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis, Cancer Res., 60(6), 1645-1653, 2000.
61. Itoh, M., Noutomi, T., Toyota, H., and Mizuguchi, J., Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential, Oral Oncol., 39(3), 269-276, 2003.
62. Custodio, J. B., Cardoso, C. M., Madeira, V. M., and Almeida, L. M., Mitochondrial permeability transition induced by the anticancer drug etoposide, Toxicol. In Vitro, 15(4, 5), 265-270, 2001.
63. Fujino, M., Li, X. K., Kitazawa, Y., Guo, L., Kawasaki, M., Funeshima, N., Amano, T., and Suzuki, S., Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells), J. Pharmacol. Exp. Ther., 300(3), 939-945, 2002.
64. Robertson, J. D., Gogvadze, V., Zhivotovsky, B., and Orrenius, S., Distinct pathways for stimulation of cytochrome c release by etoposide, J. Biol. Chem., 275(42), 32438-32443, 2000.
65. Marchetti, P., Zamzami, N., Joseph, B., Schraen-Maschke, S., Mereau-Richard, C., Costantini, P., Metivier, D., Susin, S. A., Kroemer, G., and Formstecher, P., The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus, Cancer Res., 59(24), 6257-6266, 1999.
66. Murphy, M. P., Slip and leak in mitochondrial oxidative phosphorylation, Biochim. Biophys. Acta, 977, 123-141, 1989.
67. Murphy, M. P. and Smith, R. A., Drug delivery to mitochondria: The key to mitochondrial medicine, Adv. Drug Deliv. Rev., 41(2), 235-250, 2000.
68. Modica-Napolitano, J. S. and Aprille, J. R., Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells, Adv. Drug Deliv. Rev., 49(1, 2), 63-70, 2001.
69. Modica-Napolitano, J. S. and Aprille, J. R., Basis for the selective cytotoxicity of rhodamine 123, Cancer Res., 47(16), 4361-4365, 1987.
70. Modica-Napolitano, J. S. and Singh, K. K., Mitochondria as targets for detection and treatment of cancer, Expert Rev. Mol. Med. 2002 April 11; 2002:1-19.
71. Modica-Napolitano, J. S., Koya, K., Weisberg, E., Brunelli, B. T., Li, Y., and Chen, L. B., Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077, Cancer Res., 56(3), 544-550, 1996.
72. Manetta, A., Emma, D., Gamboa, G., Liao, S., Berman, M., and DiSaia, P., Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor, Gynecol. Oncol., 50(1), 38-44, 1993.
73. Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., and Chen, L. B., Dequalinium, atopical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation, Proc. Natl. Acad. Sci. USA, 84(15), 5444-5448, 1987.
74. Christman, J. E., Miller, D. S., Coward, P., Smith, L. H., and Teng, N. N., Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies, Gynecol. Oncol., 39(1), 72-79, 1990.
75. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B., Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells, J. Biol. Chem., 260(25), 13844-13850, 1985.
76. Koya, K., Li, Y., Wang, H., Ukai, T., Tatsuta, N., Kawakami, M., Shishido, T., and Chen, L. B., MKT-077, anovel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation, Cancer Res., 56(3), 538-543, 1996.
77. Weisberg, E. L., Koya, K., Modica-Napolitano, J., Li, Y., and Chen, L. B., In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function, Cancer Res., 56(3), 551-555, 1996.
78. Chiba, Y., Kubota, T., Watanabe, M., Matsuzaki, S. W., Otani, Y., Teramoto, T., Matsumoto, Y., Koya, K., and Kitajima, M., MKT-077, localized lipophilic cation: Antitumor activity against human tumor xenografts serially transplanted into nude mice, Anticancer Res., 18(2A), 1047-1052, 1998.
79. Chiba, Y., Kubota, T., Watanabe, M., Otani, Y., Teramoto, T., Matsumoto, Y., Koya, K., and Kitajima, M., Selective antitumor activity of MKT-077, adelocalized lipophilic cation, on normal cells and cancer cells in vitro, J. Surg. Oncol., 69(2), 105-110, 1998.
80. Petit, T., Izbicka, E., Lawrence, R. A., Nalin, C., Weitman, S. D., and Von Hoff, D. D., Activity of MKT 077, arhodacyanine dye, against human tumor colony-forming units, Anticancer Drugs, 10(3), 309-315, 1999.
81. Propper, D. J., Braybrooke, J. P., Taylor, D. J., Lodi, R., Styles, P., Cramer, J. A., Collins, W. C. et al., Phase Itrial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours, Ann. Oncol., 10(8), 923-927, 1999.
82. Adams, D. M., Ji, W., Barth, R. F., and Tjarks, W., Comparative in vitro evaluation of dequalinium B, anew boron carrier for neutron capture therapy (NCT), Anticancer Res., 20(5B), 3395-3402, 2000.
83. Weissig, V., Mogel, H. J., Wahab, M., and Lasch, J., Computer simulations of DQAsomes, Proceed. Intl. Symp. Control. Rel. Bioact. Mater., 25, 312, 1998.
84. Weissig, V., Lasch, L., Erdos, G., Meyer, H. W., Rowe, T. C., and Hughes, J., DQAsomes: Anovel potential drug and gene delivery system made from Dequalinium, Pharm. Res., 15(2), 334-337, 1998.
85. De Rosa, M., Gambacorta, A., and Gliozi, A., Structure, biosynthesis, and physicochemical properties of archaebacterial lipds, Microbiol. Rev., 50, 70-80, 1986.
86. Gambacorta, A., Gliozi, A., and De Rosa, M., Archaeal lipids and their biotechnological applications, World J. Microbiol. Biotechnol., 11, 115-131, 1995.
87. Weissig, V. and Torchilin, V. P., Mitochondriotropic cationic vesicles: Astrategy towards mito-chondrial gene therapy, Curr. Pharm. Biotechnol., 1(4), 325-346, 2000.
88. Weissig, V. and Torchilin, V. P., Cationic single-chain bolaamphiphiles as new materials for application in medicine and biotechnology. In Materials research society meeting, Boston, MA., EE.5.4, p. 173, 1999.
89. Weissig, V., Lizano, C., Ganellin, C. R., and Torchilin, V. P., DNA binding cationic bolasomes with delocalized charge center: Astructure-activity relationship study, STP Pharma Sci., 11, 91-96, 2001.
90. Lasch, J., Meye, A., Taubert, H., Koelsch, R., Mansa-ard, J., and Weissig, V., Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack, Biol. Chem., 380(6), 647-652, 1999.
91. Weissig, V., Lizano, C., and Torchilin, V. P., Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes, Drug Deliv., 7(1), 1-5, 2000.
92. Weissig, V., D'Souza, G. G., and Torchilin, V. P., DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria, J. Control Release, 75(3), 401-408, 2001.
93. Ravagnan, L., Marzo, I., Costantini, P., Susin, S. A., Zamzami, N., Petit, P. X., and Hirsch, F., Lonidamine triggers apoptosis via adirect, Bcl-2-inhibited effect on the mitochondrial permeability transition pore., Oncogene, 18(16), 2537-2546, 1999.
94. Jacotot, E., Costantini, P., Laboureau, E., Zamzami, N., Susin, S. A., and Kroemer, G., Mito-chondrial membrane permeabilization during the apoptotic process, Ann. N. Y. Acad. Sci., 887, 18-30, 1999.
95. van derWoude, I., Wagenaar, A., Meekel, A. A., terBeest, M. B., Ruiters, M. H., Engberts, J. B., and Hoekstra, D., Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery, Proc. Natl. Acad. Sci. USA, 94(4), 1160-1165, 1997.
96. Zuhorn, I. S. and Hoekstra, D., On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: Is that the question? J. Membr. Biol., 189(3), 167-179, 2002.
97. Wattiaux, R., Jadot, M., Warnier-Pirotte, M. T., and Wattiaux-De Coninck, S., Cationic lipids destabilize lysosomal membrane in vitro, FEBS Lett., 417(2), 199-202, 1997.
98. El Ouahabi, A., Thiry, M., Pector, V., Fuks, R., Ruysschaert, J. M., and Vandenbranden, M., The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids, FEBS Lett., 414(2), 187-192, 1997.
99. D'Souza, G. G., Rammohan, R., Cheng, S. M., Torchilin, V. P., and Weissig, V., DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells, J. Control Release, 92, 189-197, 2003.
100. D'Souza, G. G., Boddapati, S. V., and Weissig, V., Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria, Mitochon-drion, 5(5), 352-358, 2005.
101. Braguer, D., Andre, N., Carre, M., Carles, G., Gonzalves, A., and Briand, C., 92nd Annual Meeting of the American Association for Cancer Research, American Association for Cancer Research, New Orleans, LA, p. 369, 2001.
102. Carre, M., Andre, N., Carles, G., Borghi, H., Brichese, L., Briand, C., and Braguer, D., Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel, J. Biol. Chem., 277, 33664-33669, 2002.
103. Cheng, S. M., Pabba, S., Torchilin, V. P., Fowle, W., Kimpfler, A., Schubert, R., and Weissig, V., Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxel, J. Drug Deliv. Sci. Techno., 15(1), 81-86, 2005.
104. Discher, E. D. and Eisenberg, A., Polymer vesicles, Science, 297, 967-973, 2002.
105. Schuppenhauer, M., Munich Biotech: Catioms for cancer. BioCentury, The Bernstein Report on BioBusiness, May 19, A10, 2003.
106. Schmitt-Sody, M., Strieth, S., Krasnici, S., Sauer, B., Schulze, B., Teifel, M., Michaelis, U., Naujoks, K., and Dellian, M., Neovascular targetingtherapy: Paclitaxel encapsulated in cationicliposomes improves antitumoral efficacy, Clinical Cancer Research, 9(6), 2335-2341, 2003.
107. Krasnici, S., Werner, A., Eichhorn, M. E., Schmitt-Sody, M., Pahernik, S.A., Sauer, B., and Schulze, B., Effect of thesurface charge of liposomes on theiruptakebyangiogenictumor vessels, Int. J. Cancer, 105(4), 561-567, 2003.
108. Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., and McDonald, D. M., Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J. Clin. Invest., 101(7), 1401-1413, 1998.